AARDEX Group announces successful management buyout from owner WestRock (see more)

Amsterdam, 22nd International AIDS Conference: AARDEX Group presented the results of a 5-year successful project on HIV medication adherence management program, confirming the benefits of adherence feedback based on MEMS® technology. The implementation of this program in demanding low resource settings was made possible thought a grant from The Bill and Melinda Gates foundation.

The Belgian-Swiss company AARDEX Group has announced the completion of a management buyout (MBO) from owner WestRock for all activities covering Medication Event Monitoring System (MEMS®) -enabled solutions. These solutions measure and manage patients’ adherence to prescribed medications, and AARDEX will continue to collaborate with WestRock’s Multi Packaging Solutions on connected health platforms, where both companies offer tremendous customer value.